MBC-201

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMBC-201
Drug Alias Nameanti-RSV antibody (Medigen Biotechnology)MBC-201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedigen Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedigen Biotechnology Corp
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A